Purchase Order HHSN261201600628P
Award Date 9/16/16
Potential Completion Date 10/30/16
Potential Value $264K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price delivery order awarded by the National Cancer Institute, a civilian agency of the U.S. government, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $26,800.70 award is for the provision of biological kits, Illumina sequencing equipment, and associated services. Illumina has been a frequent supplier of sequencing technology and expertise to federal agencies like the NIH, CDC, USDA, and VA. This award does not utilize any set-aside...
- This is a $142,990 firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical instruments. The contract has no set-aside designation. Illumina has previously received prime federal contract awards from other agencies like the CDC, USDA, and VA to provide sequencing systems, reagents, and related services in support of genomics...
- This is a $17,508.94 firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency of the U.S. government, to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is not set aside for any special designation. Illumina has previously been awarded prime federal contracts and subcontracts by agencies like the NIH, CDC, USDA, and VA to provide a range of sequencing systems, consumables, and...
- This is a firm fixed-price Delivery Order awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $38,027.60 award is for the provision of lab supplies, specifically Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, reagents, and consumables. This Delivery Order is likely part of a larger Indefinite...
- This is a $28,749.60 firm-fixed-price delivery order contract awarded by the National Cancer Institute (NCI) to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract is for the provision of laboratory equipment and supplies, with no set-aside designation. Through this award, Illumina will provide the NCI with a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample prep kits,...
- This is a firm fixed price delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Illumina, Inc. for $12,081.90. The contract is not designated as a set-aside. Illumina, a manufacturer of genetic sequencing equipment and supplies, will provide goods and services to support genomic sequencing and analysis for research and diagnostics purposes. The award is likely part of a larger Indefinite...
- This is a firm fixed-price delivery order awarded by the National Cancer Institute, a civilian agency under the Department of Health and Human Services, to Illumina, Inc., a for-profit manufacturer of genomic sequencing and analysis products. The $24,230.96 contract provides Illumina sequencing systems, reagents, and services to support genomic research and diagnostics. The award is not associated with a set-aside program. Through past prime contract and subcontract awards, Illumina has...
- This is a firm fixed price purchase order contract awarded by the National Cancer Institute (NCI), a civilian agency, to Illumina, Inc., a for-profit manufacturer of genomics sequencing and analysis solutions. The contract, valued at $15,388.08, is for the provision of sequencing systems, reagents, and services to support genomic research and diagnostics. Illumina has a history of providing similar products and services to various federal agencies, including the NIH, CDC, USDA, and VA, under...
- This $176,155.63 firm fixed price delivery order was awarded by the Department of Health and Human Services National Institutes of Health National Cancer Institute to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. Illumina has previously provided sequencing instruments, consumables, and support services to various federal agencies like the NIH, CDC, USDA, and VA. This award appears to be for the provision of reagents and consumables to support the agency's genomic...
- This contract was awarded by the National Cancer Institute (NCI), a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a for-profit manufacturer of genetic analysis instruments and reagents. The $24,797.20 firm-fixed-price delivery order is for Illumina's sequencing systems, reagents, and consumables to support genomic sequencing and analysis research and diagnostics. No set-aside was used. Illumina has a history of providing these types of products and services to...